Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation

Peptides

Volumn 27, Issue 7, 2006, Pages 1835-1840

  Ernst, A ^a   Kohrle J ^b   Bergmann, A ^a,c  

^a SPHINGOTEC GMBH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BRAHMS AG   (Germany)

Author keywords

Concentration gradient; CSF; Enkelytin; Enkephalin; Half life; PENK A 119 159; Prohormone; Sandwich immunoassay

Indexed keywords

LEUCINE ENKEPHALIN; METENKEPHALIN; PROENKEPHALIN; PROENKEPHALIN A [119-159]; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD DONOR; CEREBROSPINAL FLUID; CIRCULATION; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; IN VITRO STUDY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SERUM; TEMPERATURE DEPENDENCE;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALINS; HUMANS; IMMUNOASSAY; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN PRECURSORS;

EID: 33744975822     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.03.008     Document Type: Article

References (45)

1. Arrer E., Meco C., Oberascher G., Piotrowski W., Albegger K., and Patsch W. Beta-trace protein as a marker for cerebrospinal fluid rhinorrhea. Clin Chem 48 (2002) 939-941
2. Augood S.J., Faull R.M.L., Love D.R., and Emson P.C. Reduction in enkephalin and substance P messenger RNS in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience 72 (1996) 1023-1036
3. Baronti F., Conanat K.E., Giuffra M., Davis T.L., Brughitta G., Iadarola M.J., et al. Opioid peptides in Parkinson's disease: effects of dopamine repletion. Brain Res 560 (1991) 92-96
4. Beinfeld M.C. Prohormone and proneuropeptide processing. Endocrine 8 (1998) 1-5
5. Birch N., and Christie D.L. Characterization of the molecular forms of proenkephalin in bovine adrenal medulla and rat adrenal, brain, and spinal cord with site-directed antiserum. J Biol Chem 261 (1986) 12213-12221
6. Calon F., Birdi S., Rajput A.H., Hornykiewicz O., Bedard P.J., and Di Paolo T. Increase of proenkephalin mRNA levels in the putamen of Parkinson disease patients with levadopa-induced dyskinesias. J Neuropathol Exp Neurol 61 (2002) 186-196
7. Comb M., Seeburg P.H., Adelman J., Eiden L., and Herbert E. Primary structure of the human met- and leu-enkephalin precursor and its mRNA. Nature 295 (1982) 663-666
8. Docherty K., and Steiner D.F. Post-translational proteolysis in polypeptide hormone biosynthesis. Annu Rev Physiol 44 (1982) 625-638
9. Drolet G., Dumont E.C., Gosselin I., Kinkead R., Laforest S., and Trottier J.-F. Role of endogenous opioid system in the regulation of the stress response. Prog Neuro Psychopharmacol 25 (2001) 729-741
10. Ferrari M.D., Odink J., Froelich M., Portielje J.E.A., and Bruyn G.W. Methionine-enkephalin in migraine and tension headache. Differences between classic migraine, common migraine and tension headache and changes during attacks. Headache 30 (1990) 160-164
11. Fleminger G., Ezra E., Kilpatrick D.L., and Udenfriend S. Processing of enkephalin-containing peptides in isolated bovine adrenal chromaffin granules. Proc Natl Acad Sci USA 80 (1983) 6418-6421
12. Goumon Y., Strub J.M., Moniatte M., Nullans G., Poteur L., Hubert P., et al. The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. Eur J Biochem 235 (1996) 516-525
13. Horikawa S., Takai T., Toyosato M., Takahashi H., Noda M., Kakidani H., et al. Isolation and structural organization of the human preproenkephalin B gene. Nature 306 (1983) 611-614
14. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., and Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258 (1975) 577-579
15. Iadarola M.J., and Mouradian M.M. Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntigton's disease and progressive supranuclear palsy. Brain Res 479 (1989) 397-401
16. Kamphius S., Erikson F., Kavelaars A., Zijlstra J., van de Pol M., Kuis W., et al. Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monocyte IL-6 production. J Neuroimmunol 84 (1998) 53-60
17. Kobari M., Ishihara N., and Yunoki K. Increase of plasma methionine-enkephalin level in patients at the acute stage of cerebral infarction. Neurol Res 10 (1988) 120-122
18. Kojima K., Kilpatrick D.L., Stern A.S., Jones B.N., and Udenfriend S. Proenkephalin: a general pathway for enkephalin biosynthesis in animal tissues. Arch Biochem Biophys 215 (1982) 638-643
19. Langemark M., Bach F.W., Ekman R., and Olesen J. Increased cerebrospinal fluid met-enkephalin immunoreactivity in patients with chronic tension-type headache. Pain 63 (1995) 103-107
20. Liston D., Patey G., Rossier J., Verbanck P., and Vanderhaeghen J.J. Processing of proenkephalin is tissue specific. Science 225 (1984) 734-737
21. McArthur J., Hill J., Peach M.J., Dodd P.H., Bennett E.J., and Holden J. Cerebrospinal fluid and serum concentrations of beta-trace protein during pregnancy. Anaesthesia 60 (2005) 163-167
22. Melegos D.N., Diamandis E.P., Oda H., Urade Y., and Hayaishi O. Immunofluorimetric assay of prostaglandin D synthase in human tissue extracts and fluids. Clin Chem 42 (1996) 1984-1991
23. Morgenthaler N.G., Struck J., Thomas B., and Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50 (2004) 234-236
24. Mosnaim A.D., Wolf M.E., Chevesich J., Callaghan O.H., and Diamond S. Plasma methionine-enkephalin levels: a biological marker for maigraine?. Headache 25 (1985) 259-261
25. Mosnaim A.D., Puente J., Wolf M.E., Callaghan O.H., Busch R., and Diamond S. Studies of the in vitro human plasma degradation of methionine-enkephalin. Gen Pharmacol 19 (1988) 729-733
26. 5-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure. Pharmacology 67 (2003) 6-13
27. Muhlbauer M., Metcalf J.C., Robertson J.T., Fridland G., and Desiderio D.M. Opioid peptides in the cerebrospinal fluid of Alzheimer's patients. Biomed Chromatogr 4 (1986) 155-158
28. Noda M., Teranishi Y., Takahashi H., Toyosata M., Notake M., Nakanishi M., et al. Isolation and structural organization of the human preproenkephalin gene. Nature 297 (1982) 431-434
29. Nyberg F., and Terenius L. Identification of high molecular weight enkephalin precursor forms in human cerebrospinal fluid. Neuropeptides 5 (1985) 537-540
30. Nyberg F., Nylander I., and Terenius L. Enkephalin-containing polypeptides in human cerebrospinal fluid. Brain Res 371 (1986) 278-286
31. Pittius C.W., Seizinger B.R., Mehraein P., Pasi A., and Herz A. Proenkephalin-A-derived peptides are present in human brain. Life Sci 33 Suppl 1 (1983) 41-44
32. Plotnikoff N.P., Faith R.E., Murgo A.J., Herberman R.B., and Good R.A. Methionine enkephalin: a new cytokine - human studies. Clin Immunol Immunpathol 82 (1997) 93-101
33. Przewlocki R., Hassan A.H.S., Lason W., Epplen C., Herz A., and Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48 (1992) 491-500
34. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 429 (2001) 79-91
35. Reiber H., Walther K., and Althaus H. Beta-trace protein as sensitive marker for CSF rhinorhea and CSF otorhea. Acta Neurol Scand 108 (2003) 359-362
36. Rosen H., Polakiewicz R.D., Benzakine S., and Bar-Shavit Z. Proenkephalin A in bone-derived cells. Proc Natl Acad Sci USA 88 (1991) 3705-3709
37. Rosen H., Krichevsky A., and Bar-Shavit Z. The enkephalinergic osteoblast. J Bone Mineral Res 13 (1998) 1515-1520
38. Salzet M., and Tasiemski A. Involvement of pro-enkephalin-derived peptides in immunity. Dev Comp Immunol 25 (2001) 177-185
39. Spruce B.A., Curtis R., Wilkins G.P., and Glover D.M. A neuropeptide precursor in the cerebellum: proenkephalin exists in subpopulations of both neurones and astrocytes. EMBO J 9 (1990) 1787-1795
40. Stachura Z., Kowalski J., Obuchowicz E., Huzarska M., and Herman Z.S. Concentration of enkephalins in cerebrospinal fluid of patients after severe head injury. Neuropeptides 31 (1997) 78-81
41. Stark M., Danielsson O., Griffith W.J., Joernvall H., and Johansson J. Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins. J Chromatogr B 754 (2001) 357-367
42. Stern A.S., Jones B.N., Shively J.E., Stein S., and Udenfriend S. Two adrenal opioid polypeptides: proposed intermediates in the processing of proenkephalin. Proc Natl Acad Sci USA 78 (1981) 1962-1966
43. Tumani H., Nau R., and Felgenhauer K. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44 (1998) 882-889
44. Wen H.L., Lo C.W., and Ho W.K.K. Met-enkephalin level in the cerebrospinal fluid of schizophrenic patients. Clin Chim Acta 128 (1983) 367-371
45. Wilson S.P. Purification of peptides derived from proenkephalin A on Bio-Rex 70. J Neurosci Methods 15 (1985) 155-163